SIGA TECHNOLOGIES INC
Close on Oct 19, 2026
- Market cap
- $225.72M
- P/E (TTM)
- –
- Dividend yield
- 19.11%
Earnings
Next report expected Nov 5, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | During market hours | $41.00M | $0.17 | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | During market hours | – | $-0.05 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 10, 2026 | During market hours | $3.80M | $-0.08 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | During market hours | $2.60M | $-0.09 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 5, 2025 | During market hours | – | $0.49 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | During market hours | – | $-0.01 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 11, 2025 | During market hours | $81.40M | $0.63 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 7, 2024 | During market hours | $10.00M | $0.02 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 1, 2024 | During market hours | $21.80M | $0.03 | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | During market hours | $25.40M | $0.14 | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 12, 2024 | During market hours | $116.50M | $1.01 | – |
Company guidance
Outlook given with results on May 8, 2025, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| orders outstanding as of December 31, 2024 to be delivered | third quarter of 2025 | $70.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Siga Technologies filed with the SEC
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026
Results of operations · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Twelve
Results of operations · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025
Results of operations · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025
Results of operations · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three Months Ended March 31, 2025
Results of operations · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Twelve
Results of operations · EX-99.1 to Form 8-K
Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment
Other events · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Nine
Results of operations · EX-99.1 to Form 8-K
Topline Results from PALM 007 Study of SIGA'S Tecovirimat in Treatment of Mpox Released
Other events · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Six
Results of operations · EX-99.1 to Form 8-K
SIGA Announces U.S. Government Procurement Order of
Other events · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three Months Ended March 31, 2024
Results of operations · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Twelve
Results of operations · EX-99.1 to Form 8-K
SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023
Results of operations · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023
Results of operations · EX-99.1 to Form 8-K
SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX®
Other events · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three Months Ended March 31, 2023
Results of operations · EX-99.1 to Form 8-K
SIGA Declares Special Cash Dividend of $0.45 Per Share
Other events · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2022
Results of operations · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2022
Results of operations · EX-99.1 to Form 8-K
SIGA Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Million for IV TPOXX®
Other events · EX-99.0 to Form 8-K
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2022
Results of operations · Executive or director change · EX-99.1 to Form 8-K
SIGA Announces Approximately $28 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)
Other events · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three Months Ended
Results of operations · EX-99.1 to Form 8-K
SIGA Declares Special Dividend of $0.45 Per Share
Other events · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2021
Results of operations · EX-99.1 to Form 8-K
SIGA Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2021
Results of operations · EX-99.1 to Form 8-K